van Spronsen D J, Vrints L W, Hofstra G, Crommelin M A, Coebergh J W, Breed W P
Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands.
Br J Haematol. 1997 Feb;96(2):322-7. doi: 10.1046/j.1365-2141.1997.d01-2010.x.
The importance of the subclassification of nodular sclerosing Hodgkin's disease (NSHD) according to the British National Lymphoma Investigation Group (BNLI) criteria, which had an independent prognostic value for 90 unselected patients diagnosed in our region in the period 1972-83, is still equivocal. Because survival of patients with Hodgkin's disease improved in our region during the period 1972-92 and because treatment may modify prognostic factors, we re-evaluated the prognostic value of NSHD subclassification up to 1993. A registry-based study was performed with data on all 345 Hodgkin patients diagnosed in the period 1972-92. Available histology was reviewed. The prognostic value of nodular sclerosis (NS) grading was evaluated for two periods, 1972-80 and 1981-92, designated as the seventies and the eighties, respectively. NSHD was diagnosed in 57% (n = 195) of all registered cases of Hodgkin's disease, 17 of which could not be evaluated. NS stage I (NSI; 73%) and NS stage II (NSII; 27%) patients exhibited the same distribution of stage during both periods; NSII patients were older than NSI patients in the seventies. NSII patients presented with an elevated ESR and B symptoms more frequently during the eighties and subsequently received combined modality therapy more often. The crude 5-year survival rate for grade I v grade II NSHD was 85% v 38% (P < 0.05) for the seventies and 84% v 83% for the eighties. Subclassification of NSHD was not an independent prognostic factor after adjustment for age, stage, gender, B symptoms and ESR, though it remained of independent prognostic value when ESR was left out of the Cox model. The most important factors adversely influencing survival were advanced age, advanced stage and male gender. The independent prognostic value of the subclassification of NSHD has disappeared, as reflected by the clearly improved survival of NSII patients, probably due to more intensive treatment in the eighties, whereas survival of NSI patients did not changes.
根据英国国家淋巴瘤研究小组(BNLI)标准对结节硬化型霍奇金病(NSHD)进行亚分类的重要性仍不明确,该标准对1972年至1983年期间在我们地区确诊的90例未经选择的患者具有独立的预后价值。由于我们地区霍奇金病患者的生存率在1972年至1992年期间有所提高,且治疗可能会改变预后因素,因此我们重新评估了截至1993年NSHD亚分类的预后价值。我们进行了一项基于登记处的研究,收集了1972年至1992年期间确诊的所有345例霍奇金病患者的数据。对现有的组织学进行了复查。分别对1972年至1980年和1981年至1992年这两个时期(分别称为七十年代和八十年代)的结节硬化(NS)分级的预后价值进行了评估。在所有登记的霍奇金病病例中,57%(n = 195)被诊断为NSHD,其中17例无法评估。NSI期(NSI;73%)和NSII期(NSII;27%)患者在两个时期的分期分布相同;在七十年代,NSII期患者比NSI期患者年龄更大。在八十年代,NSII期患者出现血沉(ESR)升高和B症状的频率更高,随后接受综合治疗的频率也更高。七十年代,I级与II级NSHD的5年粗生存率分别为85%和38%(P < 0.05),八十年代为84%和83%。在对年龄、分期、性别、B症状和ESR进行调整后,NSHD的亚分类不是一个独立的预后因素,尽管当ESR被排除在Cox模型之外时,它仍然具有独立的预后价值。对生存产生不利影响的最重要因素是高龄、晚期和男性。NSHD亚分类的独立预后价值已经消失,这从NSII期患者生存率的明显提高可以看出,这可能是由于八十年代治疗更加积极,而NSI期患者的生存率没有变化。